MedPath

The surveillance regarding the ultra-rapid insulin glulisine (Apidra)

Not Applicable
Conditions
Type1 Diabetes
Registration Number
JPRN-UMIN000006908
Lead Sponsor
aozora clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Pregnant 2) Patient that doctor cannot screen properly because of any reason.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath